Stem Cell Therapeutics Wins US Patent

Biotechnology company Stem Cell Therapeutics has received a US patent for production of neural stem cells. The patent covers the production of oligodendrocytes from neural stem cells in culture. The technology covered by the patent has potential use as transplant therapy for diseases of damaged neurons, including MS, ALS, and spinal cord injury.

Click here to read more.

Share this: